The difference in surface phenotypes between cytotoxic lymphocytes induced in vivo by systemic administration of human recombinant interleukin-2 and lymphokine activated killer cells induced in vitro

1988 ◽  
Vol 24 (6) ◽  
pp. 1055-1060 ◽  
Author(s):  
Akira Ozaki ◽  
Hidehiko Nakano ◽  
Koichi Minato ◽  
Kazuhiko Nakagawa ◽  
Yasutsuna Sasaki ◽  
...  
Keyword(s):  
Interleukin 2 ◽  
Systemic Administration ◽  
Cytotoxic Lymphocytes ◽  
Lymphokine Activated Killer Cells ◽  
Killer Cells ◽  
Recombinant Interleukin 2 ◽  
The Difference

In vivo administration of low-dose human interleukin-2 induces lymphokine-activated killer cells for enhanced cytolysis in vitro

1991 ◽  
Vol 132 (2) ◽  
pp. 277-284 ◽  
Author(s):  
Gerald E. Hancock ◽  
Anthony Molloy ◽  
A.B. Birhane Kale ◽  
Rolf Kiessling ◽  
Marijke Becx-Bleumink ◽  
...  
Keyword(s):  
Low Dose ◽  
Interleukin 2 ◽  
Lymphokine Activated Killer Cells ◽  
Killer Cells ◽  
In Vivo Administration

Continuous infusion of recombinant interleukin-2 and lymphokine-activated killer cells in refractory malignancies

1989 ◽  
Vol 17 (5-6) ◽  
pp. 455-458 ◽  
Author(s):  
Neal P. Christiansen ◽  
B. J. Kennedy ◽  
Augusto C. Ochoa ◽  
Keith M. Skubitz ◽  
Fritz H. Bach
Keyword(s):  
Continuous Infusion ◽  
Interleukin 2 ◽  
Lymphokine Activated Killer Cells ◽  
Killer Cells ◽  
Recombinant Interleukin 2
Sign in / Sign up

Export Citation Format

Share Document